Express Scripts Dropped Wegovy or Zepbound? Your Next Steps
If your employer’s Express Scripts plan just stopped paying for GLP-1 weight-loss injections, you still have options. Follow this step-by-step playbook to confirm the change, appeal it, and keep treatment affordable.
Most Express Scripts members can still get Wegovy or Zepbound covered, but only if their specific employer or marketplace plan keeps the drug on its formulary or approves an exception. Start by checking your plan document, then work with your prescriber to submit the right prior-authorization or appeal paperwork, and use a manufacturer savings card while you wait. If final approval fails, cash-pay programs-including Rx.com’s $99/month GLP-1 plan-can cut out-of-pocket costs by more than 90 percent.
- Wegovy’s list price is $1,349.02 for a 28-day pen pack, while Zepbound lists at $1,059.87 for the same supply (Novo Nordisk).
- Express Scripts handles pharmacy benefits for about 112 million Americans, but each employer decides whether to cover weight-loss GLP-1s (express-scripts.com).
- Plans that drop Wegovy or Zepbound must still process formulary exception or medical-necessity appeals within 72 hours for urgent requests (cms.gov).
- NovoCare and LillyDirect savings cards can lower first-month copays to $0 and limit refills to $25-$99 if your commercial insurance still covers the drug.
- Denied patients can switch to cash-pay: NovoCare offers Wegovy at $935, LillyDirect sells Zepbound at $550, and Rx.com’s GLP-1 program starts at $99/month.
What did Express Scripts actually change?
Express Scripts publishes a National Preferred Formulary, but large employers and marketplace plans customize it. Only a minority removed Wegovy or Zepbound for 2026. Before you panic, verify whether your own plan dropped the drug or simply added stricter prior-authorization rules.
Key document: Look for the 2026 Drug Formulary or Benefit Booklet on your employer’s HR portal. GLP-1 weight-loss drugs usually live in the “Antiobesity Agents” row.
| Possible Status Line | What It Means for You |
|---|---|
| Covered: Tier 3, PA required | You need a prior authorization, often BMI ≥ 30 or BMI ≥ 27 with a comorbidity. |
| NF (Non-Formulary) | Not covered unless you win a formulary exception. |
| Excluded Class | No exceptions allowed, you must pay cash. |
Why some plans drop GLP-1 weight-loss drugs
Employers pay Express Scripts a per-member claim cost, so they may exclude high-demand drugs to control premiums. Wegovy and Zepbound can each add over $10,000 per member per year to pharmacy spend, and demand surged 240 percent between 2024 and 2026, according to Express Scripts’ own Drug Trend Report.
Stop-loss fear: Self-funded employers must cover the full claim amount until stop-loss insurance kicks in, which can be financially daunting when many employees initiate therapy at once.
How to confirm your current Wegovy or Zepbound coverage
Check three sources to avoid surprises.
1. Online portal: Log into Express-Scripts.com or the mobile app and run a “Price a Medication” lookup for Wegovy and Zepbound. The result will show “Covered,” “Requires PA,” or “Not Covered.”
2. Customer service: Call the number on your card and ask specifically, “Is HCPCS code J3490 for tirzepatide injection covered under my pharmacy benefit?” Make note of the call reference number.
3. Prescriber fax: Your provider can submit an electronic Benefit Investigation. Express Scripts returns a coverage determination within 24 hours.
Should you bother filing an appeal?
Check the column that fits your situation:
✅ Appeal likely to succeed
- BMI ≥ 40 and serious weight-related complications
- Documented 5 percent weight loss on Wegovy or Zepbound
- Failed first-line oral therapies (orlistat, phentermine)
- Provider letter cites AACE or ADA obesity guidelines
🏥 Appeal unlikely to succeed
- Seeking drug for cosmetic weight loss only
- No comorbidities and BMI below plan criteria
- Already denied after external review
- Plan booklet lists “Anti-obesity agents excluded”
How to win a formulary exception or appeal
Open with the medical necessity. Your prescriber should explain why weight loss is critical to control your hypertension, sleep apnea, fatty liver disease, or other ICD-10 codes. Attach:
- Progress notes showing prior treatments and weight-loss response
- Specialist letters (endocrinologist, cardiologist) supporting therapy
- Recent labs: A1C, ALT, lipid panel (to prove metabolic risk)
Timeline tips: Express Scripts must answer standard appeals within 15 days or 72 hours if your doctor marks it urgent (cms.gov).
| Appeal Step | Average Turnaround | Approval Rate* |
|---|---|---|
| Initial prior authorization | 2-4 days | 68 % |
| First-level appeal | 10-15 days | 45 % |
| External review | 30-45 days | 27 % |
*Express Scripts 2025 utilization-management disclosure (express-scripts.com).
Using manufacturer savings while appeals are pending
NovoCare Wegovy Savings Offer: Commercially insured patients pay $0 for the first prescription and as little as $25 for each refill, up to $225 maximum saving per 28-day supply (novocare.com).
LillyDirect Zepbound Savings Card: First fill $0, refills $25 with pharmacy-benefit coverage or $550 cash pay if not covered (lillydirect.com).
Because both programs require an active prescription, ask your prescriber to send the script to a LillyDirect or Wegovy partner pharmacy immediately after filing the appeal.
Cash-pay options if coverage is gone for good
Compare list prices, direct-to-consumer programs, and discount cards.
| Path | Monthly Cost | Key Requirements |
|---|---|---|
| NovoCare Wegovy Cash Offer | $935 | Active prescription, sign up online, ships to local pharmacy |
| LillyDirect Zepbound Cash Offer | $550 | Prescription from LillyDirect provider or your own |
| Rx.com Weight-Loss Program | $99-$149 | Online visit with licensed provider, ships to your door |
| Retail pharmacy with a free discount card | $850-$1,200* | Bring coupon from Rx.com discount card |
*Price range based on October 2026 cash quotes at major U.S. chains.
Even if you ultimately buy through a direct program, keep filing appeals. Winning later can retro-bill past claims and save thousands.
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Severe abdominal pain: could signal gallbladder or pancreas inflammation.
- Persistent vomiting: risk of dehydration and electrolyte imbalance.
- Rapid heartbeat or palpitations: may indicate cardiovascular stress.
- Difficulty breathing or swelling of the face: possible allergic reaction.
- Severe depression or thoughts of self-harm: rare but reported mood changes; call or text 988 if in crisis.
- Vision changes: report immediately, especially if diabetic retinopathy is present.
- Signs of thyroid mass: neck swelling or hoarseness warrants an ultrasound.
Scientific References
- Welcome to Novo in the U.S. | Novo U.S. Website. novonordisk-us.com.
- Express Scripts Members: Manage Your Prescriptions Online. express-scripts.com.
- Home: Centers for Medicare & Medicaid Services | CMS. cms.gov.
- Support Starts Here for Patients Taking Novo Medicines | NovoCare®. novocare.com.
- Just a moment. lillydirect.com.
Frequently Asked Questions
Did Express Scripts completely ban Wegovy and Zepbound for everyone?
No. Express Scripts supplies a template formulary, but each employer and marketplace plan customizes coverage. Some kept the drugs with stricter prior authorization, others moved them to non-formulary, and a few excluded the entire anti-obesity class.
How long does a formulary exception request usually take?
A standard request must receive a decision within 15 days, but you can ask your doctor to mark it urgent to trigger a 72-hour turnaround under federal rules for life-threatening conditions.
Can I switch to Ozempic or Mounjaro instead?
Possibly. Many plans still cover Ozempic or Mounjaro when prescribed for type 2 diabetes. However, using them solely for weight loss if you do not have diabetes could violate plan rules and may be considered off-label.
Will Medicare cover Wegovy or Zepbound?
Medicare Part D does not cover anti-obesity drugs, but the temporary GLP-1 Bridge demonstration allows short-term coverage for certain beneficiaries at high cardiovascular risk. Check eligibility on the CMS site.
Can my doctor bill Wegovy under the medical benefit instead of pharmacy?
Rarely. Express Scripts administers the pharmacy benefit. Billing under the medical side would require your plan to allow “buy and bill,” and very few do for self-injectable GLP-1s.
Is there a limit to how many times I can appeal?
You generally have one internal appeal and, if denied, an external review by an independent board. After that, only new clinical evidence or a plan-year reset lets you refile.
What if my state mandates obesity-treatment coverage?
Some states, like West Virginia and Michigan, require ACA marketplace plans to cover at least one anti-obesity drug. Employer self-funded plans are exempt, so confirm which law governs your coverage.
